{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:36:07Z","timestamp":1778326567834,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.leukres.2010.02.034","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T04:37:53Z","timestamp":1269491873000},"page":"950-953","source":"Crossref","is-referenced-by-count":16,"title":["A novel gallium compound synergistically enhances bortezomib-induced apoptosis in mantle cell lymphoma cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Christopher R.","family":"Chitambar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Purpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.02.034_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0093-7754(03)00173-8","article-title":"Gallium nitrate in the treatment of lymphoma","volume":"30","author":"Straus","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.leukres.2010.02.034_bib2","doi-asserted-by":"crossref","first-page":"682A","DOI":"10.1182\/blood.V104.11.2487.2487","article-title":"Phase 2 multicenter trial of gallium nitrate in patients with advanced non-Hodgkin's lymphoma (NHL)","volume":"104","author":"Pro","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.034_bib3","first-page":"41","article-title":"Common pathway for tumor cell uptake of Gallium-67 and Iron-59 via a transferrin receptor","volume":"64","author":"Larson","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2010.02.034_bib4","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI112746","article-title":"Effects of different transferrin forms on transferrin receptor expression, iron uptake and cellular proliferation of human leukemic HL60 cells: mechanisms responsible for the specific cytotoxicity of transferrin-gallium","volume":"78","author":"Chitambar","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2010.02.034_bib5","first-page":"3929","article-title":"Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms","volume":"47","author":"Chitambar","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2010.02.034_bib6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood.V72.6.1930.1930","article-title":"Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea","volume":"72","author":"Chitambar","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.034_bib7","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1158\/1535-7163.MCT-06-0285","article-title":"Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition","volume":"5","author":"Chitambar","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2010.02.034_bib8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/jpet.107.126342","article-title":"Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate","volume":"322","author":"Chitambar","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.leukres.2010.02.034_bib9","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2010.02.034_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bcp.2003.10.031","article-title":"Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells","volume":"67","author":"Daniel","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2010.02.034_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.leukres.2010.02.034_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0163-7258(01)00159-0","article-title":"The machinery of programmed cell death","volume":"92","author":"Zimmermann","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.leukres.2010.02.034_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5414\/CPP43590","article-title":"Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors\u2014a CESAR study (Central European Society for Anticancer Drug Research\u2014EWIV)","volume":"43","author":"Hofheinz","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.leukres.2010.02.034_bib14","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1200\/jco.2008.26.15_suppl.8592","article-title":"Initial phase I clinical and pharmacokinetic assessment of G4544, an oral gallium-containing compound","volume":"26","author":"Novick","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.02.034_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0162-0134(02)00419-1","article-title":"Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine 4N-dimethylthiosemicarbazone","volume":"91","author":"Arion","year":"2002","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.leukres.2010.02.034_bib16","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1158\/0008-5472.CAN-07-1813","article-title":"Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:28:35Z","timestamp":1591158515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0145212610001177"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.02.034","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}